Moving Analytics: Virtual Cardiac Rehabilitation

Helping reverse the effects of heart disease

Doctor tapping into screen behind floating heart
Written by

Alumni Ventures

Published on

Alumni Ventures portfolio company Moving Analytics has developed a remote cardiac rehabilitation program that aims to improve the quality of life for those who have suffered cardiac episodes.

Heart disease is one of the leading causes of mortality in the United States. According to the CDC, a person dies every 36 seconds from cardiovascular disease — or roughly 659,000 heart disease-related deaths every year. For those that survive major cardiovascular events, the physical rehabilitation required can make the difference between a positive outcome or long-term negative health effects. Especially for those at risk of further cardiac events, it is crucial to adopt a rehab regimen that takes into account a patient’s specific needs while minimizing the possibility of future cardiac events.

The CDC estimates that heart disease costs the U.S. economy $363 billion annually — a significant amount that is borne not only by individuals, but by private and public organizations as well. Moving Analytics’ solution aims to reduce barriers to access and improve outcomes for post-emergency care of cardiac patients while reducing the societal costs of those afflicted by heart disease.

A Recovery-Focused Telehealth Platform

Moving Analytics has created an interactive, remote, and physician-supervised virtual cardiac rehabilitation program to mitigate the impact of heart disease through exercise training, risk factor modification, medication therapy, and more. The company delivers its program through a web-based portal, patient-facing mobile app, and biometric-focused care kit. The result is a streamlined and accessible rehabilitation experience that patients access from the comfort of their homes.

Interview with Co-Founder Ade Adesanya

See video policy below.

What We Like About Moving Analytics

Strong Value Proposition: The program has clinically proven it can reduce readmission rates for post-acute patients. This digital-first treatment plan improves nearly all aspects of patient health in a cost-effective and convenient way.

Market Tailwinds: The global pandemic in 2020 spurred many patients to transition to telehealth. This wave of adoption has eroded barriers to onboarding users, creating favorable market conditions for the product.

Experienced Investor Syndicate: Lead investor Seae Ventures is based in Boston and invests in healthtech companies at the Seed, Series A, and Series B stages. The team has extensive experience in the healthcare space both as operators and investors.

Co-investor Philips Ventures is the VC arm of multinational healthtech corporation Philips. Nick Pappas, Head of Investments at Philips Ventures and a Board Member for Moving Analytics, had this to say about the company:

“Moving Analytics [is] a leading innovator in developing and scaling post-acute cardiac virtual care. … The company has demonstrated proven outcomes for patients, with compelling data from well-known health system and payer customers.”

How We Are Involved

Lakeshore Ventures (for the University of Chicago community) sponsored Alumni Ventures’ investment in Moving Analytics, alongside sibling fund Waterman Ventures (for the Brown community) and AV’s Total Access Fund. Together, the funds participated in Moving Analytics’ $20 million Series A led by Seae Ventures.

Want to learn more?
View all our available funds and secure data rooms, or schedule an intro call.

New to AV?
Sign up and access exclusive venture content.

Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit av-funds.com/disclosures.

These videos feature members of portfolio companies in which certain Alumni Ventures Funds have invested and may contain factual or forward-looking statements of such members. Neither AV nor any of its affiliated companies represents, warrants, or guarantees the accuracy or the completeness of the information. You agree not to rely on the information contained herein for any investment, business, or financial purpose.